Cells | Free Full-Text | Agonist Effects of Propranolol on Non-Tumor Human Breast Cells
Propranolol Reduces the Development of Lesions and Rescues Barrier Function in Cerebral Cavernous Malformations | Stroke
Propranolol exhibits activity against hemangiomas independent of beta blockade | npj Precision Oncology
Propranolol in the treatment of infantile hemangioma: clinical effectiveness, risks, and recommendations | Actas Dermo-Sifiliográficas
Molecular mechanism of propranolol in the treatment of hemangiomas. IH,... | Download Scientific Diagram
Hypothetical model of propranolol mechanism of action | Download Scientific Diagram
Frontiers | Topical Timolol Vs. Oral Propranolol for the Treatment of Superficial Infantile Hemangiomas
Propranolol inhibits growth of hemangioma-initiating cells but does not induce apoptosis | Pediatric Research
PDF) Mechanisms of propranolol action in infantile hemangioma
Pingyangmycin stimulates apoptosis in human hemangioma‑derived endothelial cells through activation of the p53 pathway
Propranolol therapy for infantile hemangioma: our experience | DDDT
Propranolol Participates in the Treatment of Infantile Hemangioma by Inhibiting HUVECs Proliferation, Migration, Invasion, and Tube Formation
Identification of putative biomarkers for Infantile Hemangiomas and Propranolol treatment via data integration | Scientific Reports
Management of Head and Neck Hemangiomas in Adults: Oral Propranolol Versus Oral Itraconazole in Conjugation with Injection Sodium Tetra Decyl Sulphate | SpringerLink
Identification of putative biomarkers for Infantile Hemangiomas and Propranolol treatment via data integration | Scientific Reports
IJMS | Free Full-Text | The Role of Propranolol as a Repurposed Drug in Rare Vascular Diseases
Possible mechanisms of action of propranolol in infantile hemangiomas... | Download Scientific Diagram
Propranolol Therapy for Infantile Hemangioma
JCM | Free Full-Text | Propranolol: A “Pick and Roll” Team Player in Benign Tumors and Cancer Therapies
Adverse effects of propranolol when used in the treatment of hemangiomas: A case series of 28 infants - ScienceDirect
JCI - A transcription factor is the target of propranolol treatment in infantile hemangioma
Possible mechanisms of action of propranolol in infantile hemangiomas... | Download Scientific Diagram
Mechanisms of propranolol action in infantile hemangioma
JCI - Non–beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma